Cargando…

PRAME as diagnostic marker and as regulator for cell fate decisions in germ cell cancers

Detalles Bibliográficos
Autor principal:	Neuhaus, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985358/ https://www.ncbi.nlm.nih.gov/pubmed/27441497 http://dx.doi.org/10.1038/bjc.2016.217

Ejemplares similares

The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
por: Nettersheim, Daniel, et al.
Publicado: (2016)

Germline stem cells are critical for sexual fate decision of germ cells
por: Tanaka, Minoru
Publicado: (2016)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

Transcriptional metabolic reprogramming implements meiotic fate decision in mouse testicular germ cells
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma
por: Spel, Lotte, et al.
Publicado: (2015)

Genetic mechanism for the loss of PRAME in B cell lymphomas
por: Mraz, Marek
Publicado: (2022)

PRAME expression and clinical outcome of breast cancer
por: Epping, M T, et al.
Publicado: (2008)

Metabolic regulation of pluripotency and germ cell fate through α‐ketoglutarate
por: Tischler, Julia, et al.
Publicado: (2018)

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022)

Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply.
por: Takata, Katsuyoshi, et al.
Publicado: (2022)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

The Expansion of the PRAME Gene Family in Eutheria
por: Chang, Ti-Cheng, et al.
Publicado: (2011)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Posttranscriptional regulation of T helper cell fate decisions
por: Hoefig, Kai P., et al.
Publicado: (2018)

Editorial: Chromatin Regulation in Cell Fate Decisions
por: Brumbaugh, Justin, et al.
Publicado: (2021)

Chemical reprogramming of Caenorhabditis elegans germ cell fate
por: Morgan, Clinton T., et al.
Publicado: (2009)

Dual Function Molecules and Processes in Cell Fate Decision: A Preface to the Special Issue
por: Emanuele, Sonia, et al.
Publicado: (2020)

The Challenge of Melanocytic Lesions in Pediatric Patients: Clinical-Pathological Findings and the Diagnostic Value of PRAME
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

Fate Decisions of Chicken Primordial Germ Cells (PGCs): Development, Integrity, Sex Determination, and Self-Renewal Mechanisms
por: Ichikawa, Kennosuke, et al.
Publicado: (2023)

Nutritional and metabolic control of germ cell fate through O‐GlcNAc regulation
por: Hayashi, Yohei, et al.
Publicado: (2023)

Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
por: Lee, Koon H, et al.
Publicado: (2020)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Enigma variations: control of sexual fate in nematode germ cells
por: Ellis, Ronald E
Publicado: (2006)

On the fate of primordial germ cells injected into early mouse embryos()
por: Leitch, Harry G., et al.
Publicado: (2014)

Therapeutic targeting of PRAME with (mTCR)CAR T cells in acute myeloid leukemia
por: Kirkey, Danielle C., et al.
Publicado: (2022)

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2(Prame) complex
por: Zhang, Wenjuan, et al.
Publicado: (2021)

GLS-1, a Novel P Granule Component, Modulates a Network of Conserved RNA Regulators to Influence Germ Cell Fate Decisions
por: Rybarska, Agata, et al.
Publicado: (2009)

PRAME Promotes Cervical Cancer Proliferation and Migration via Wnt/β-Catenin Pathway Regulation
por: Chen, Xin, et al.
Publicado: (2023)

Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)

Mitochondrial Dynamics in the Drosophila Ovary Regulates Germ Stem Cell Number, Cell Fate, and Female Fertility
por: Garcez, Marcia, et al.
Publicado: (2021)

Oxygen and Cell Fate Decisions
por: Lin, Qun, et al.
Publicado: (2008)

Zika in the United States of America and a Fateful 1969 Decision
por: Hotez, Peter J.
Publicado: (2016)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g8jp1gikri6n45jf7baqle1dfb